Growing community of inventors

Rodgau, Germany

Herbert Sindermann

Average Co-Inventor Count = 3.33

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Herbert SindermannJurgen Engel (2 patents)Herbert SindermannEckhard Günther (2 patents)Herbert SindermannJürgen Engel (2 patents)Herbert SindermannGilbert Mueller (4 patents)Herbert SindermannBabette Aicher (1 patent)Herbert SindermannNicola Ammer (1 patent)Herbert SindermannGilbert Muller (1 patent)Herbert SindermannRichard Sachse (1 patent)Herbert SindermannHerbert Sindermann (5 patents)Jurgen EngelJurgen Engel (81 patents)Eckhard GüntherEckhard Günther (23 patents)Jürgen EngelJürgen Engel (10 patents)Gilbert MuellerGilbert Mueller (4 patents)Babette AicherBabette Aicher (4 patents)Nicola AmmerNicola Ammer (2 patents)Gilbert MullerGilbert Muller (1 patent)Richard SachseRichard Sachse (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aeterna Zentaris Gmbh (5 from 36 patents)

2. Æterna Zentaris Gmbh (2 patents)


5 patents:

1. 10288629 - Method of assessing growth hormone deficiency in humans by a macimorelin containing composition

2. 8551977 - Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

3. 8507710 - Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

4. 8389497 - Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals

5. 8383605 - Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…